Optimizing sequential treatment with anti-EGFR and VEGF mAb in metastatic colorectal cancer: current results and controversies

Por Chen, Datian, Gu, Kaikai, Wang, Huiyu
Publicado no Cancer Manag Res (2019)

Should anti-EGFR mAbs be discontinued for conversion surgery in untreated right-sided metastatic colorectal cancer? A systematic review and meta-analysis

Por Chen, Datian, Zhang, Xiang, Gao, Guangyi, Shen, Lili, Xie, Jiaqi, Qian, Xiaoping, Wang, Huiyu
Publicado no World J Surg Oncol (2018)

FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal...

Por Chen, Datian, Li, Li, Zhang, Xiang, Gao, Guangyi, Shen, Lili, Hu, Jing, Yang, Mi, Liu, Baorui, Qian, Xiaoping
Publicado no Medicine (Baltimore) (2018)